A review of the role of anticoagulation for patients with infective endocarditis and embolic stroke
Open Access
- 13 April 2016
- journal article
- review article
- Published by Wiley in Clinical Case Reports
- Vol. 4 (5) , 513-516
Abstract
Key Clinical Message: Stroke is a common embolic complication of infective endocarditis. The most important treatment to prevent stroke in endocarditis is the initiation of antibiotic therapy. It is unclear whether the initiation of de novo anticoagulation (i.e, warfarin) in patients with infective endocarditis is beneficial, since there are no large or randomized controlled trials in this area. However, this case report suggests, despite the limited evidence, that anticoagulation in this patient caused no harm and could suggest a hint of possible benefit.Keywords
This publication has 5 references indexed in Scilit:
- Warfarin therapy and incidence of cerebrovascular complications in left-sided native valve endocarditisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Major Cerebral Events in Staphylococcus Aureus Infective Endocarditis: Is Anticoagulant Therapy Safe?Cardiology, 2009
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st CenturyArchives of internal medicine (1960), 2009
- Neurologic Manifestations of Infective EndocarditisArchives of internal medicine (1960), 2000
- Infective Endocarditis Due to Staphylococcus aureusArchives of internal medicine (1960), 1999